Objective: Langerhans cell histiocytosis (LCH) is an uncommon neoplasm of dendritic cells and predominantly occurs in children and young adults. The study aims to evaluate cytopathologic features and current diagnostic concepts in a large series of LCH on fine needle aspiration (FNA). Study Design: We retrospectively searched the pathology archives of The Johns Hopkins Hospital (JHH) and Emory University Hospital (EUH) to identify all FNA cases diagnosed as LCH in a period of 21 years. Cytologic material and immunohistochemical stains were reviewed. Results: A total of 37 LCH patients (26 from JHH and 11 from EUH) with FNA diagnoses were identified. The sites of LCH included bone in 28, soft tissue of head and neck in 6, and lymph nodes in 3. Thirty-one patients (84%) were diagnosed as LCH, 4 (11%) had a descriptive diagnosis suggesting scant cellularity with epithelioid/histiocyte-like cells and mixed inflammation, and 2 (5%) were non-diagnostic due to insufficient cellularity. Immunohistochemical stains were performed on cell block sections in 26 cases, showing 24 of 24 (100%) positive for CD1a, 22 of 23 (96%) positive for S100-protein, and 3 of 3 (100%) positive for CD68. Conclusions: LCH can be accurately diagnosed in FNA based on the characteristic cytomorphology and selected immunohistochemistry. Diagnosis may be difficult in cases with scant or insufficient cellular material.

Keywords:
Langerhans cell histiocytosis, Fine needle aspiration, Cytopathology
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.